Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix Drops Suit against PacBio

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix has dropped a lawsuit it had filed against Pacific Biosciences and several former employees that had joined PacBio, according to GenomeWeb Daily News sister publication In Sequence.

In Sequence reported yesterday that Affy settled its claims against PacBio in December. The settlement was confirmed by both Affy and PacBio officials. While Affy declined to comment on terms of the settlement, a PacBio spokesperson said that "the matter was resolved by mutual agreement, and involved no financial terms."

In the suit, which was filed in early November in the Superior Court of the State of California, County of Santa Clara, Affy accused PacBio of luring away at least 15 of its former employees in order to get an unfair competitive advantage in the market.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.